US03828A1016
© BusinessWire
12.12.2025
APLT
LISTED
NASDAQ
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Applied Therapeutics, Inc. (NASDAQ: APLT) to Cycle Group Holdings Limited for $0.088 per share in cash plus one non-transferrable contingent value right entitling the holder to receive potential additional payments under certain conditions is fair to Applied shareh...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.12.2025
APLT
LISTED
NASDAQ
Cycle Pharmaceuticals to Acquire Applied Therapeutics
News Preview
Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Reports Third Quarter 2025 Financial Results
News Preview
– Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
28.10.2025
APLT
LISTED
NASDAQ
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Applied Therapeutics, Inc. (NASDAQ: APLT) breached their fiduciary duties to shareholders.
If you currently own Applied stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.09.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Provides Update Following Meeting with FDA
News Preview
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the Company completed a meeting with the U.S. Food and Drug Administration (FDA) to discuss the potential new drug...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Reports Second Quarter 2025 Financial Results
News Preview
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Announces Key Leadership Appointments
News Preview
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced key appointments to its executive leadership team with the promotions of Evan Bailey, MD, to Chief Medical Officer (CMO), effective June 15, 2025, and...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.05.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
News Preview
Slowing of progression of disease observed via MRI at 24 months...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.05.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Reports First Quarter 2025 Financial Results
News Preview
- Company to present full 12-month clinical data and new topline 18-month and 24-month data from INSPIRE registrational Phase 3 trial of govorestat in CMT-SORD Deficiency at the Peripheral Nerve Society 2025 Annual Meeting...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.05.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
News Preview
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month and 24-month data from patients prior to open-label extension Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-mont...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.04.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
News Preview
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.03.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
News Preview
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it has filed a Form 12b-25, Notification of Late Filin...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
19.03.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
News Preview
Dr. Baumgartner will advance Applied’s preparation for upcoming regulatory interactions Dr. Baumgartner will advance Applied’s preparation for upcoming regulatory interactions...
Themefolio
Profiler
Peergroup
© BusinessWire
18.02.2025
APLT
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against t...
Themefolio
Profiler
Peergroup
© BusinessWire
15.02.2025
APLT
LISTED
NASDAQ
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company.
For more information, submit a form, email a...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
APLT
LISTED
NASDAQ
Deadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2...
Themefolio
Profiler
Peergroup
© BusinessWire
05.02.2025
APLT
LISTED
NASDAQ
APLT DEADLINE ALERT: Kirby McInerney LLP Alerts Applied Therapeutics, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit
News Preview
The law firm of Kirby McInerney LLP alerts investors of the imminent February 18, 2025 deadline, to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities between January 3, 2024, to December 2, 2024 (“t...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
APLT
LISTED
NASDAQ
Kirby McInerney LLP Urges Investors in Applied Therapeutics, Inc. (APLT) to Inquire About Their Rights in Class Action Lawsuit
News Preview
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities between January 3, 2024, to December 2, 2024 (“the Class Peri...
Themefolio
Profiler
Peergroup
© BusinessWire
03.02.2025
APLT
LISTED
NASDAQ
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2025
APLT
LISTED
NASDAQ
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality
News Preview
Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industries Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industries...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2025
APLT
LISTED
NASDAQ
Deadline Alert: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming February 18, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
03.01.2025
APLT
LISTED
NASDAQ
Deadline Approaching: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming February 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2025
APLT
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusi...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2024
APLT
LISTED
NASDAQ
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Def...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2024
APLT
LISTED
NASDAQ
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Investors
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). Applied Therapeutics investors have until February 18,...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2024
APLT
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Applied Therapeutics, Inc. (APLT) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). Applied Therapeutics investors have until February 18...
Themefolio
Profiler
Peergroup
© BusinessWire
24.12.2024
APLT
LISTED
NASDAQ
APLT Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc.
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
22.12.2024
APLT
LISTED
NASDAQ
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Def...
Themefolio
Profiler
Peergroup
© BusinessWire
21.12.2024
APLT
LISTED
NASDAQ
APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned A...
Themefolio
Profiler
Peergroup
© BusinessWire
19.12.2024
APLT
LISTED
NASDAQ
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action laws...
Themefolio
Profiler
Peergroup
© BusinessWire
19.12.2024
APLT
LISTED
NASDAQ
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Excha...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
APLT
LISTED
NASDAQ
Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”). Applied Therapeutics is a clinical-stage biopharmaceutical company.
For more...
Themefolio
Profiler
Peergroup
© BusinessWire
12.12.2024
APLT
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a l...
Themefolio
Profiler
Peergroup
© BusinessWire
12.12.2024
APLT
LISTED
NASDAQ
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) investors concerning the Company’s possible violations of federal securities laws.
On November 27, 2024, Applied Therapeutics disclosed that it had received a Complete Response Letter (“CRL”)...
Themefolio
Profiler
Peergroup
© BusinessWire
12.12.2024
APLT
LISTED
NASDAQ
The Law Offices of Frank R. Cruz Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On November 27, 2024, Applied...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
APLT
LISTED
NASDAQ
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
News Preview
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2024
APLT
LISTED
NASDAQ
Applied Therapeutics Reports Second Quarter 2024 Financial Results
News Preview
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the second quarter ended June 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.07.2024
APLT
LISTED
NASDAQ
Applied Therapeutics Added to Russell 3000® Index
News Preview
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company was added to the Russell 3000® Index, effective after the U...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.05.2024
APLT
LISTED
NASDAQ
Applied Therapeutics Reports First Quarter 2024 Financial Results
News Preview
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the first quarter ended March 31, 2024....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
